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Abstract
Background:  Dimerization is an important regulatory mechanism of single membrane-spanning
r e c e p t o r s .  F o r  i n s t a n c e ,  a c t i v a t i o n  o f  r e c e p t o r  p r o t e i n - t y r o s i n e  k i n a s e s  ( R P T Ks )  i n v o l v e s
dimerization.  Structural,  functional  and  biochemical  studies  suggested  that  the  enzymatic
counterparts of RPTKs, the receptor protein-tyrosine phosphatases (RPTPs), are inhibited by
dimerization, but whether RPTPs actually dimerize in living cells remained to be determined.
Results:  In order to assess RPTP dimerization, we have assayed Fluorescence Resonance Energy
Transfer (FRET) between chimeric proteins of cyan- and yellow-emitting derivatives of green
fluorescent protein, fused to RPTPα , using three different techniques: dual wavelength excitation,
spectral  imaging  and fluorescence  lifetime  imaging.  All  three  techniques  suggested  that FRET
occurred between RPTPα  -CFP and -YFP fusion proteins, and thus that RPTPα  dimerized in living
cells.  RPTPα   dimerization  was  constitutive,  extensive  and  specific.  RPTPα   dimerization  was
consistent with cross-linking experiments, using a non-cell-permeable chemical cross-linker. Using
a panel of deletion mutants, we found that the transmembrane domain was required and sufficient
for dimerization.
Conclusions:  We demonstrate here that RPTPα  dimerized constitutively in living cells, which
may be mediated by the transmembrane domain, providing strong support for the model that
dimerization is involved in regulation of RPTPs.
Introduction
Protein phosphorylation on tyrosine residues is one of
the most important eukaryotic cell signalling mecha-
nisms, and cellular protein phosphotyrosine (pTyr) lev-
els are regulated by the antagonistic activities of the
protein-tyrosine kinases (PTKs) and protein-tyrosine
phosphatases (PTPs) [1]. Our insight into the function of
PTPs - in contrast to the PTKs - is limited. However, in
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recent years evidence is emerging that PTPs play impor-
tant and specific roles in biological processes [2,3,4].
Transmembrane PTPs, tentatively called receptor PTPs,
RPTPs, are interesting, because their diverse extracellu-
lar domains may function as ligand binding domains.
Recently, Pleiotrophin was identified as a ligand of RP-
TPβ /ζ , and binding of Pleiotrophin led to inactivation of
RPTPβ /ζ  activity, resulting in increased tyrosine phos-
phorylation of its substrate, β -Catenin [5]. The mecha-
nism underlying ligand-induced modulation of RPTP
activity remains to be determined.
Dimerization is a well-established regulatory mecha-
nism for single membrane-spanning receptors [6,7],
which may be involved in regulation of RPTPs. The crys-
tal structure of RPTPα -D1, which is highly homologous
to other PTPs [8,9,10,11,12,13,14], showed that an ami-
no-terminal helix-turn-helix wedge-like segment inter-
acts with the dyad-related monomer, in such a manner
that both catalytic sites in the dimer are occluded [9]. It
should be noted that the crystal structures of RPTPµ -D1
and of the complete cytoplasmic domain of LAR do not
show dimers like RPTPα  [11,12]. Functional experiments
with EGFR/CD45, a chimeric protein, consisting of the
extracellular domain of the Epidermal Growth Factor
Receptor (EGFR) and the intracellular domain of the RP-
TP, CD45, demonstrated that ligand-induced dimeriza-
tion leads to functional inactivation of CD45 [15].
Mutation of a single residue in the wedge of CD45 abol-
ishes dimerization-induced functional inactivation [16].
The importance of tight regulation of CD45 was demon-
strated by the introduction of a targeted point mutation
in the wedge in mice. The CD45 E613R mutation causes
lymphoproliferation and autoimmunity in mice, result-
ing in death [17]. RPTPα  dephosphorylates and activates
the PTK c-Src [18,19,20,21] via a phosphotyrosine dis-
placement mechanism, involving Src pTyr529 and RPT-
Pα  pTyr789 [22]. Recently, we demonstrated that forced
dimerization of RPTPα  by introduction of a disulfide
bridge in the extracellular domain leads to inactivation
of RPTPα  as assessed by analysis of c-Src Tyr529 phos-
phorylation and activity. Similar to CD45 [16], dimeriza-
tion-induced inactivation of RPTPα  was dependent on
an intact wedge [23]. Therefore, it is clear that RPTPs
can be regulated by dimerization. Experiments with
chemical cross-linkers indicated that RPTPα  forms dim-
ers [24]. The use of chemical cross-linkers to analyze
protein-protein interactions has many disadvantages
due to the fact that detection of the interaction is indi-
rect. Here we report the analysis of RPTPα  dimerization
in living cells using a non-invasive, non-destructive
method, Fluorescence Resonance Energy Transfer
(FRET).
FRET is a method to assess distances at the molecular
level. FRET is a direct radiation-less transfer of energy
from the excited donor fluorophore to the acceptor fluor-
ophore, which occurs if the two fluorophores are in very
near vicinity of each other, usually less than 60Å
[25,26,27]. Recently, FRET has been applied to analyse
interactions between proteins, fused to derivatives of
Green Fluorescent Protein (GFP) [28,29]. For instance,
GFP-FRET has been used to assay changes in cytosolic
Ca2+-concentrations using "cameleons" [30,31], to probe
interactions between Bcl-2 and Bax in mitochondria
[32], to visualize nuclear interactions of Pit-1 with other
transcription factors [33], to analyze interactions be-
tween nuclear import factors [34], to assess dimerization
of G protein coupled receptors [35], and to follow the in-
teraction between GRB2 and the Epidermal Growth Fac-
tor Receptor (EGFR) in vivo [36].
We have assayed FRET between fusion proteins of RPT-
Pα , fused to CFP and YFP, by dual wavelength excitation,
spectral imaging microscopy (SPIM) and fluorescence
lifetime imaging microscopy (FLIM), and found that
FRET occurred, using all three methods, suggesting that
RPTPα  dimerized constitutively. The FRET results were
consistent with experiments using chemical cross-link-
ers. Finally, using deletion mutants, we mapped a site of
interaction to the transmembrane domain, and demon-
strate that the transmembrane domain is sufficient to
drive dimerization. Our results provide strong support
for the model that RPTPs are regulated by dimerization,
and may be useful for analysis of factors that modulate
RPTPalpha dimerization.
Results
FRET between RPTPalpha-GFP fusion proteins
In order to determine whether RPTPα  formed dimers in
living cells, we generated RPTPα -fusion proteins by sub-
stitution of RPTPα -D2 with CFP or YFP, a good donor-
acceptor fluorophore pair for FRET [30,31] (Fig. 1A). RP-
TPα -516-CFP and RPTPα -516-YFP (individually, or in
combination) were transiently transfected into SK-N-
MC neuroepithelioma cells. RPTPα -516-YFP localized to
the cell membrane as assessed by confocal microscopy
(Fig. 1B). Similarly, RPTPα -516-CFP localized to the cell
membrane (data not shown). The excitation spectra were
determined in single living cells, using two filter sets,
confirming that the excitation maxima are 452 and 514
nm for CFP and YFP, respectively [30,31], and that there
was little overlap between the two excitation spectra
(Fig. 1C). The excitation spectrum of a cell that coex-
pressed RPTPα -516-CFP and RPTPα -516-YFP suggested
that FRET occurred, since a strong signal was detected at
the YFP emission wavelength (curve 4, Fig. 1C) upon ex-
citation below 440 nm (predominantly exciting CFP),
whereas this signal was nearly absent in single RPTPα -BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
Figure 1
Expression and spectral properties of chimeric fluorescent RPTPα  proteins. (A) Schematic representation of wild type RPTPα
(RPTPα  and RPTPα -516-XFP, a construct in which either CFP or YFP (indicated by XFP) was inserted at position 516, thereby
replacing the membrane distal PTP domain, D2. The extracellular domain (ED), transmembrane domain (black box), mem-
brane-proximal domain (D1) and membrane-distal domain (D2) are indicated. (B) Confocal micrograph of a single SK-N-MC
neuroepithelioma cell transfected with an expression vector for RPTPα -516-YFP, illustrating membrane localization of RPTPα -
516-YFP. (C) SK-N-MC cells were transfected with RPTPα -516-CFP (traces 1 and 2), RPTPα -516-YFP (trace 3), or both (trace
4). Excitation spectra of single, live cells were corrected for background and are depicted using filter #1 (longpass 490
nm)(trace 1), allowing detection of CFP, and using filter #2 (bandpass 530-560 nm)(traces 2 - 4), optimal for detection of YFP.
Filter #2 is the FRET filter, allowing detection of FRET when CFP and YFP are in a protein complex.BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
516-CFP or RPTPα -516-YFP transfected cells (compare
with curves 2 and 3). FRET between RPTPα -516-CFP
and RPTPα -516-YFP suggested that RPTPα  dimerized
under these conditions.
Routinely, we determined fluorescence intensities in sin-
gle living cells following excitation at 440 nm and 490
nm, using the FRET filter. Initially, we used RPTPα -516-
CFP/-YFP, human EGFR-CFP/-YFP as a negative con-
trol, and constitutively dimeric RPTPα -P137C-CFP/-
YFP as a positive control (Fig. 2A). The F(440)/F(490)
ratio consists of three terms: direct YFP emission, direct
CFP emission, and sensitized emission (directly propor-
tional to FRET efficiency (E) and dimerization (α ), two
terms that cannot be separated from each other (see Ma-
terials and Methods). We have calculated the theoretical
values of F(440)/F(490) under conditions of no dimeri-
zation (E *α  = 0), and substantial dimerization (E *α  =
0.5), and plotted these values against the ratio of the
CFP- and YFP-concentrations R(CFP/YFP) (Fig. 2B). It
is clear from Fig. 2B that F(440)/F(490) is substantially
higher under conditions of dimerization and FRET (E *α
= 0.5) than under conditions of no FRET and/or dimeri-
zation (E *α  = 0). In addition, it is clear that changes in
the CFP:YFP expression ratio affect F(440)/F(490). We
have indicated the theoretical F(440)/F(490) levels un-
der conditions of no dimerization and/or FRET with
R(CFP/YFP) = 0.5 (F(440)/F(490) = 0.25) and R(CFP/
YFP) = 1.5 (F(440)/F(490) = 0.37) (Fig. 2B, bottom and
top dashed lines, respectively). We have analysed protein
expression of the CFP- and YFP-fusion proteins by im-
munoblotting and found roughly similar expression lev-
els for all the fusion proteins that we used, which was
expected since the only difference between these pro-
teins is a limited number of point mutations (six) that af-
fect the fluorophore. The ratio of concentrations of CFP
and YFP was close to 1.0 for all fusion protein pairs, and
certainly 0.5<R(CFP/YFP) <1.5. Hence, if the experi-
mental F(440)/F(490) for any CFP/YFP fusion protein
pair is 0.25 or less, there is no dimerization and/or
FRET. If F(440)/F(490) > 0.37, our simulations (Fig.
2B) indicate that FRET and hence a physical interaction
(dimerization) occurs. If 0.25 < F(440)/F(490) < 0.37,
one cannot distinguish whether the increased value is
caused by a high CFP:YFP expression ratio in the cells or
by dimerization-induced CFP to YFP FRET with this
method. We postulate that under our experimental con-
ditions with similar amounts of CFP and YFP fusion pro-
teins expressed in the total cell population, an average
F(440)/F(490) ratio value >0.37 for a large group of in-
dividual cell measurements is the result of FRET and
dimerization.
The  F(440)/F(490) ratio of coexpressed RPTPα -516-
CFP and -YFP was 0.46±0.07 (Fig. 2C), while the expres-
sion levels were similar (Fig. 2D), suggesting constitutive
dimerization and FRET. As a control, we determined the
F(440)/F(490) ratio of EGFR-CFP and -YFP, which was
0.20±0.05, suggesting there was no dimerization and/or
FRET (Fig. 2C, D). To induce constitutive dimerization,
we substituted Pro137 in the extracellular domain of
RPTPα  with cysteine. RPTPα -P137C formed a disulfide
bridge, thus inducing constitutive homodimerization,
and more than 80% of RPTPα -P137C was detected in the
dimeric form by SDS-PAGE under non-reducing condi-
tions [23] (Fig. 2E). The F(440)/F(490) ratio of constitu-
tively dimeric RPTPα - P137C-CFP/-YFP was 0.50±0.07
(Fig. 2C) with similar expression of the -CFP and - YFP
fusion proteins (Fig. 2D). Since the F(440)/F(490) ratios
of RPTPα -516-CFP/- YFP and RPTPα -P137C-CFP/-YFP
were comparable and well above the FRET/dimerization
threshold of 0.37, we conclude that dimerization of wild
type RPTPα  was constitutive and extensive. 
RPTPalpha dimerization assessed by SPIM and FLIM
In order to validate the excitation-ratio FRET data and
exclude artefacts due to aberrant CFP:YFP expression
ratios, we performed additional FRET-experiments for
the full length RPTPα -CFP and -YFP fusion proteins us-
ing other methods and equipment. With SPIM, fluores-
cence emission spectra can be determined from living
cells with spatial resolution along one dimension
[37,38]. Using this technique, several spectra were ob-
tained from plasma membranes of single living SK-N-
MC neuroepithelioma cells that were cotransfected with
RPTPα -CFP and either RPTPα - YFP or EGFR-YFP (con-
trol). From Fig. 3A it can be inferred that the RPTPα -CFP
+ RPTPα -YFP coexpressing cells displayed a clearly in-
creased relative fluorescence at wavelengths between
500 and 600 nm, with a maximum increase at 527 nm
upon excitation at 435 nm. The increased relative fluo-
rescence closely matched a YFP emission spectrum,
which was almost absent in control cells where similar
amounts of RPTPα -CFP and EGFR-YFP were expressed.
These data suggest that the increased YFP fluorescence
observed in RPTPα -CFP and RPTPα -YFP double trans-
fected cells is due to sensitized YFP emission resulting
from CFP to YFP FRET.
To exclude the possibility that the increased YFP emis-
sion was caused by a high YFP to CFP expression ratio,
we performed FLIM experiments on the very same cells
by employing the other detector port of the SPIM-FLIM
imaging microscope. FRET causes a decrease in the do-
nor (i.e. CFP) fluorescence lifetime [25,38]. As shown in
Fig. 3B, the CFP-fluorescence lifetimes (τφ ) were lower in
case of the RPTPα -CFP and RPTPα -YFP coexpressing
cells than in control cells, coexpressing RPTPα -CFP and
EGFR-YFP. The decrease in the CFP-fluorescence life-
time from 2.6 ns to 2.2 ns clearly demonstrated CFP toBMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
Figure 2
Specific and constitutive dimerization of RPTPα , as assessed by FRET. (A) Schematic representation of the constructs that
were used. RPTPα -D2 was replaced by CFP or YFP in RPTPα -516-XFP. Pro137 was mutated to Cys in RPTPα -P137C-XFP and
RPTPα -P137C, leading to the formation of a disulfide bridge, and thus to constitutive dimerization. In EGFR-XFP, the C-termi-
nus of the EGFR was replaced by CFP or YFP. (B) Theoretical values of F(440)/F(490), calculated as described in the Experi-
mental Procedures section for no FRET and/or dimerization (bottom trace), or significant dimerization (E *α  = 0.5, upper
trace). The dashed lines indicate the F(440)/F(490) levels under conditions of no FRET and/or dimerization with R(CFP/YFP) =
0.5 (lower dashed line), or R(CFP/YFP) = 1.5 (upper dashed line). F(440)/F(490) levels close to the lower dashed line indicate
that no FRET and/or dimerization occurs. F(440)/F(490) values above the upper dashed line are most likely due to FRET.
F(440)/F(490) values  between  the two  dashed lines are  ambiguous,  since F(440)/F(490) values may indicate high CFP:YFP
expression ratios and no FRET and/or dimerization, or low CFP:YFP expression ratios and little FRET and dimerization. (C)
SK-N-MC cells were transiently transfected with combinations of CFP- and YFP-fusion proteins, fused to RPTP α -516, to the
EGFR, or to constitutively dimeric RPTPα -P137C. The F(440)/F(490) ratios were determined in at least 10 single living cells
from at least two independent experiments, and the error bars indicate the standard deviation. The dashed lines indicate the
theoretically minimal F(440)/F(490) ratio (bottom dashed line), and the FRET threshold level (upper dashed line). (D) Expres-
sion of the fusion proteins in (C) was monitored by immunoblotting to verify that similar levels of fusion proteins were
expressed, using an anti-GFP antibody (left two panels), or an anti-HA-tag antibody (right panel). (E) Wild type RPTPα  and
RPTPα -P137C were transfected into SK-N-MC cells. Lysates of these cells were run on 5% SDS-PAGE gels under reducing
(+β -mercaptoethanol,  β -ME)  or  non-reducing  conditions  (-β -ME).  Immunoblots,  probed  with  anti-RPTPα   antibodies  are
depicted with the molecular weight of marker proteins that were co-electrophoresed with the samples on the left (in kDa).
The position of monomeric (M) and dimeric (D) RPTPα  is depicted on the right.BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
Figure 3
SPIM and FLIM confirm FRET in full length RPTPα -CFP and -YFP expressing cells. (A) Normalized uncorrected fluorescence
emission spectra of plasma membrane regions of single SK-N-MC cells expressing both RPTPα -CFP and RPTPα -YFP (closed
circles) or SK-N-MC cells expressing both RPTPα -CFP and EGFR-YFP (control, open circles) as obtained by fluorescence
spectral imaging microscopy (SPIM). The emission spectra were normalized to the first emission peak of the CFP spectrum (at
475 nm) for comparative reasons (note that due to this normalization procedure no 'quenching' of CFP fluorescence due to
FRET seems apparent from the figure). (B) CFP-fluorescence lifetime images (τφ , calculated from the phase shift) of cells
expressing both RPTPα -CFP and RPTPα -YFP (left) or RPTPα -CFP and EGFR-YFP (control, right). The histogram represents
the distribution of fluorescence lifetimes throughout the image. (C) Correlation between FLIM and SPIM data of cells express-
ing both RPTPα -CFP and RPTPα -YFP (closed symbols) or RPTPα -CFP and EGFR-YFP (control, open symbols). Each point rep-
resents a combined SPIM and FLIM measurement of a single cell. On the horizontal axis the normalized intensity of the
emission spectrum at 527 nm is indicated (which is proportional to the YFP/CFP fluorescence emission ratio). Lifetimes deter-
mined from phase (τφ ) and modulation (τ M) are plotted with circles and squares, respectively. Regression analysis indicated a -
85% and -88% correlation coefficient for the respective lines. Error bars represent pixel-by-pixel standard deviations in fluores-
cence lifetimes or fluorescence emission spectra.BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
YFP FRET due to close proximity of the two fluoro-
phores, which cannot be explained by variation in
CFP:YFP expression ratios [38]. The control CFP-life-
time of 2.6 ns was identical to that of cells expressing cy-
tosolic (unfused) CFP which has a τφ  lifetime of 2.6 ns at
the employed modulation frequency (data not shown,
see also [38]). Because the reduction in CFP lifetime was
rather low, we correlated the lifetime data with the SPIM
data (see Fig. 3C). A clear negative correlation was ob-
served between the emission ratios and the CFP fluores-
cence lifetimes (both τφ  and τ M). These data confirm the
notion that the increased YFP fluorescence for the RPT-
Pα -CFP and RPTPα -YFP coexpressing cells (Fig. 3A) in-
deed reflects sensitized emission resulting from FRET.
Furthermore, the experiments in Fig. 3A and 3C also
show that the FRET is not due to nonspecific RPTPα  in-
teractions as a result of high concentrations in the plas-
ma membrane, since the control with EGFR-YFP did not
show sensitized YFP emission. Hence these FRET exper-
iments demonstrate a specific RPTPα -RPTPα  interac-
tion (i.e. dimerization) in the plasma membrane of living
SK-N-MC neuroepithelioma cells.
Cross-linking of RPTPalpha using a chemical cross-linker
We used the non-cell-permeable irreversible chemical
cross-linker, bis- [sulfosuccinimidyl]suberate (BS3), on
intact cells to confirm that RPTPα -YFP dimerized. A
considerable proportion of RPTPα -YFP, designated long
form (L) (Fig. 4A), migrated with an apparent molecular
weight that was consistent with dimerization following
treatment of the cells with BS3 (indicated by LL) (Fig.
4B). The proportion of cross-linked dimers appeared to
be low. It is noteworthy that - similar to RPTPα -YFP -
less than 10% of the constitutively dimeric RPTPα -P137C
was cross-linked by BS3 (data not shown), suggesting
that the efficiency of cross-linking was low under these
conditions. These results are similar to previously pub-
lished results with wild type RPTPα , lacking GFP deriva-
tives [24], indicating that the GFP-derivatives neither
enhanced nor interfered with RPTPα -YFP dimerization.
We tested dimerization of a deletion mutant of RPTPα ,
enabling us to investigate whether RPTPα  homodimer-
ized, or merely interacted with another protein of similar
size. RPTPα -200-CFP, lacking almost the entire cyto-
plasmic domain, including the wedge, had an apparent
molecular weight of approximately 110 kDa, and was
designated short form (S) (Fig. 4A). RPTPα -200-CFP
migrated as a dimer following treatment of the cells with
BS3 (indicated by SS) (Fig. 4B). Dimerization of the short
form appeared to be more efficient than of the long form
(Fig. 4B). However, we cannot exclude that this is due -
in part - to an artefact as a result of more efficient blot-
ting of smaller proteins. Co-transfection of RPTPα -YFP
(L) and RPTPα -200-CFP (S) followed by treatment with
BS3 led to the formation of LL-dimers, SS-dimers, and a
novel intermediate form, LS-heterodimers. Mixing of
lysates from BS3-treated cells transfected with only RPT-
Pα -YFP or RPTPα -200-CFP illustrated that the LS het-
erodimer was only detected after BS3-treatment of cells
co-expressing RPTPα -YFP and RPTPα -200-CFP (Fig.
4B). Thus, BS3-mediated cross-linking confirmed the
FRET measurements, and the heterodimerization re-
sults of the long and short forms demonstrated that RP-
TPα  homodimerized specifically.
Mapping of the region involved in dimerization
In order to establish which regions in RPTPα  were re-
quired for dimerization, we determined the F(440)/
F(490) ratio of a panel of RPTPα  mutants. Initially, we
focussed on the region that is involved in dimerization in
the crystal structure of RPTPα  [9]. Subtle mutations and
deletions of (part of) the wedge diminished RPTPα
dimerization as assessed using the chemical cross-linker
BS3 [24]. Surprisingly, neither subtle mutations, nor de-
letion of the entire wedge reduced FRET significantly
(data not shown). Therefore, we generated additional de-
letion mutants and determined the F(440)/F(490) ratio
(Fig. 5A, B). Neither deletion of D2 (RPTPα -516), D1 and
D2 (RPTPα -250), nor deletion of the wedge, D1 and D2
(RPTPα -200) reduced the F(440)/F(490) ratio signifi-
cantly. Expression of all the different CFP and YFP fu-
sion protein pairs was similar (Fig. 5C). Some
transmembrane domains are sufficient for dimerization,
e.g. the transmembrane domain of glycophorin A [39].
To test whether the transmembrane domain of RPTPα
was involved in dimerization, we deleted the extracellu-
lar domain of the RPTPα -200-CFP and -YFP constructs,
rendering fusion proteins that consisted of little more
than the RPTPα  transmembrane domain and CFP or
YFP (Fig. 5A). Analysis of the F(440)/F(490) ratio in
cells transfected with RPTPα -200∆  ED-CFP and -YFP
demonstrated that deletion of the extracellular domain
did not reduce dimerization significantly (Fig. 5), indi-
cating that the extracellular domain was not required for
dimerization. To test the specificity of transmembrane
domains in dimerization, we replaced RPTPα 's trans-
membrane domain with the transmembrane domain of
the EGFR (Fig. 5A) and found that the F(440)/F(490) ra-
tio of cells coexpressing RPTPα -200-YFP and RPTPα -
EGFR-200-CFP was close to the theoretical minimum
(bottom dashed line) (Fig. 5B). The chimeric RPTPα
EGFR-200-CFP and -YFP proteins did not homodimer-
ize either (Fig. 5B). These results demonstrate that the
transmembrane domain of RPTPα  was sufficient for
dimerization of RPTPα
Discussion
Here, we provide evidence that RPTPα  dimerized in liv-
ing cells. We have successfully used FRET to detect RPT-
Pα  dimers and dimerization was consistent with cross-BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
Figure 4
Homodimerization of RPTPα  as assessed using a chemical cross-linker. (A) Distinct RPTPα  constructs with different molecular
weights were used to be able to discriminate between them. The long form (L) is a full length RPTPα  construct with YFP fused
to the C-terminus, while the short form (S) lacks almost all cytoplasmic sequences and contains CFP fused to residue 200,
close to the transmembrane domain. (B) SK-N-MC cells were transiently transfected with the constructs depicted in (A). The
cells were treated with the non-cell-permeable cross-linker, bis [sulfosuccinimidyl]suberate (BS3), or left untreated, as indi-
cated. Aliquots of the total cell lysates were run on a 5% SDS-polyacrylamide gel, the gel was blotted, and the immunoblot was
probed with anti-HA-tag antibody. The positions of marker proteins that were co-electrophoresed with the samples are indi-
cated on the left (in kDa). The position of monomeric RPTPα -YFP (the long form, L), dimeric RPTPα -YFP (LL), monomeric
RPTPα -200-CFP (the short form, S), dimeric RPTPα -200-CFP (SS), and of the RPTPα -YFP/ RPTPα -200-CFP heterodimer (LS)
are indicated, as well as a non-specific band (NS). Lysates from BS3-treated cells that had been transfected with either RPTPα -
YFP or RPTPα -200-CFP were mixed (mix), clearly demonstrating that the heterodimer (LS) only formed in cells that had been
co-transfected with RPTPα -YFP and RPTPα -200-CFP.BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
Figure 5
The transmembrane domain mediates RPTPα  dimerization. (A) Schematic representation of RPTPα  and deletion mutants.
RPTPα  fused to XFP (RPTPα -XFP) and deletion mutants lacking D2 (RPTPα -516-XFP), D1 and D2 (RPTPα -250-XFP), the
entire cytoplasmic domain (RPTPα -200-XFP), or the cytoplasmic domain and the extracellular domain (RPTPα -200 ED-XFP)
are depicted. RPTPα -EGFR-200-XFP is identical to RPTPα -200-XFP, except that the transmembrane and a short part of the
intracellular domain were replaced by the corresponding regions of the human EGFR (depicted on the right). XFP (X) repre-
sents either YFP or CFP. The RPTPα  extracellular domain (ED) is indicated, as well as the transmembrane domain (RPTPα ,
black box; EGFR, open box), the wedge (triangle) and the two PTP domains (D1 and D2). The EGFR ligand binding domain
(LBD) and tyrosine kinase (TK) domain are indicated on the right. ( B) Deletion mutants of RPTPα , fused to CFP and YFP
(depicted in A), were co-transfected as indicated, and F(440)/F(490) was determined in single living cells. Averages of at least 10
individual cells from at least two independent experiments are depicted with error bars indicating the standard deviation. The
dashed lines indicate theoretical minimal F(440)/F(490) ratio (bottom dashed line), and the FRET threshold level (upper dashed
line). According to a two-tailed student's t-test, all values except for RPTPalpha-200-YFP/ RPTPalpha-EGFR-200-CFP are signif-
icantly different from the negative control, RPTPalpha-EGFR-200-CFP/ -YFP (p<0.003). (C) Expression of the constructs that
were used in (B) was monitored by SDS-polyacrylamide gel electrophoresis using different gels (7.5 - 12.5%, depending on the
size of the construct), and immunoblotting, using an anti-HA-tag antibody as a probe, to verify that CFP and YFP were
expressed at similar levels. The molecular weights of the fusion proteins are: RPTPα -XFP, 160 kDa; RPTPα -516-XFP, 130 kDa;
RPTPα -250-XFP, 110 kDa; RPTPα -200-XFP, 104 kDa; RPTPα -200∆  ED-XFP, 50 kDa; RPTPα -EGFR-200-XFP, 104 kDa.BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
linking experiments. Our results provide strong support
for the model that dimerization is involved in regulation
of RPTPs.
FRET was detected between RPTPα -CFP and RPTPα -
YFP using three different techniques: dual wavelength
excitation (Fig. 2), SPIM (Fig. 3A) and FLIM (Fig. 3B).
The excitation-ratio method for determining FRET suf-
fers from uncertainties when the CFP:YFP expression ra-
tios, R(CFP/YFP), are not exactly known. Simulations
show that high excitation ratios can be caused either by
FRET or by an unfavorable (high) R(CFP/YFP) (Fig. 2B).
Although for the entire cell population R(CFP/YFP) ex-
pression ratios were close to 1 (Fig. 2D), one cannot de-
termine the expression ratio independently from FRET
at the single cell level. Using the SPIM-method, FRET
can be mimicked by unfavorable CFP/YFP expression ra-
tios, but, in contrast to the excitation-ratio method, only
when the R(CFP/YFP) is very low. The most reliable (but
less sensitive) technique is FLIM. In conclusion, ratio-
metric analysis of FRET by dual wavelength excitation is
a sensitive method for detection of FRET, which is relia-
ble when similar levels of the two fluorophores are ex-
pressed.
We also demonstrated that RPTPα  dimerized by chemi-
cal cross-linking, a technique that is fundamentally dif-
ferent from FRET analysis. BS3-mediated chemical
cross- linking is a two-step chemical reaction, leading to
a covalent bond, while FRET is only dependent on the
distance between the two fluorophores. Dimerization,
detected by chemical cross-linking appeared to be much
less efficient than with FRET. However, this apparent
difference is caused by the relatively low efficiency of the
cross-linker, BS3. Only ∼  10% of RPTPα -P137C was de-
tected in dimeric form following BS3-mediated cross-
linking, like wild type RPTPα  (data not shown), while ∼
80% of RPTPα -P137C dimerized according to non-dena-
turing gels (Fig. 2E). According to the FRET analysis
dimerization was extensive, since similar FRET levels
were detected in wild type RPTPα  as in constitutively
dimeric RPTPα -P137C (Fig. 2). Taken together, both
FRET and cross-linking experiments indicate that
dimerization of RPTPα  is extensive. Subtle changes, for
instance in the wedge, did not affect dimerization detect-
ed by FRET, but did lead to detection of reduced dimeri-
zation according to the cross-linking experiments [24].
This discrepancy may be explained by the difference in
detection of dimerization. The extracellular domain may
dimerize, without an interaction intracellularly. There-
fore, extracellular cross-linkers may allow detection of
these dimers, while FRET analysis does not, due to the
topology of the two fluorophores in the intracellular do-
mains. Importantly, the requirements for detection of
dimerization are more stringent for cross-linkers than
for FRET, since the linker between the two reactive
groups in BS3 is only ∼  12Å, while FRET allows distances
up to ∼  60Å between the two fluorophores. It is notewor-
thy that a distance of 60Å or less between the two fluor-
ophores is only achieved when the two proteins are in a
protein complex, not when they merely colocalize subcel-
lularly. Taken together, both cross-linking and FRET
analysis show that RPTPα  dimerizes extensively.
FRET analysis demonstrated that the transmembrane
domain was sufficient to drive dimerization of RPTPα
which is consistent with cross-linking experiments [24]
(Fig. 4B). Other regions in RPTPα  may be involved in
dimerization of the full length protein as well. For in-
stance, cross-linking experiments demonstrated that the
extracellular domain dimerized by itself [24]. By con-
trast, the extracellular domain of RPTPα  fused to the
EGFR transmembrane domain did not show FRET (Fig.
5B), suggesting that this fusion protein did not dimerize.
This may be explained by the difference between cross-
linking and FRET, as described above. Yet other regions
in RPTPα  may be involved in dimerization as well. We
have evidence that RPTPα -D2 binds to RPTPα -D1 [40].
Similarly, CD45 and RPTPµ  may be engaged in intra-or
intermolecular interactions [41,42]. In addition, we and
others found heterodimerization between RPTP-D1s and
RPTP-D2s from different RPTPs, suggesting cross-talk
between RPTPs [40,43]. It is noteworthy that the wedge
is not required for dimerization, since deletion of the
wedge did not abolish dimerization (Fig. 5, data not
shown). Nevertheless, the wedge may be involved in sta-
bilization of the dimer, since mutations in the wedge de-
creased the cross-linking efficiency [24]. Moreover,
whereas the EGFR transmembrane domain by itself was
not sufficient to mediate dimerization (Fig. 5), introduc-
tion of the juxtamembrane domain and D1 of RPTPα
(residues 200-516) induced dimerization (data not
shown). Taken together, multiple regions in RPTPα  con-
tribute to dimerization.
Here, we demonstrate for the first time that RPTPα
dimerizes constitutively in living cells. Previously, indi-
rect detection of protein-protein interactions using
chemical cross-linkers demonstrated that CD45 ho-
modimerizes [44]. In addition, RPTPα  elutes from gel
filtration columns as a large protein complex, suggesting
dimerization or multimerization [45]. Regulation of
dimerization is ill-understood. Like dimerization of
RPTKs, dimerization of RPTPs may be regulated by lig-
and binding. RPTPs have diverse extracellular domains,
and several RPTPs bind ligands [46,47,48,49]. Interest-
ingly, GPI-linked Contactin binds laterally to the extra-
cellular domain of RPTPα , i.e. in cis on the same cell
[50]. Whether Contactin functions as a ligand, or as a lig-
and-binding moiety remains to be determined. Pleio-BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
trophin, a ligand of RPTPβ /ζ  inactivates RPTPβ /ζ
activity [5]. Whether ligand binding affects dimerization
of any of these RPTPs remains to be determined. RPTPα
dimerization was constitutive and extensive. The trans-
membrane domain of RPTPα  by itself was sufficient to
drive dimerization, suggesting that ligands are not re-
quired for dimerization. However, ligand binding may
modulate the extent of RPTPα  dimerization. Analysis of
RPTP dimerization using FRET may provide a powerful
means to screen for factors that modulate dimerization
or monomerization, and FRET may facilitate analysis of
the dynamics of RPTP dimerization.
Dimerization of RPTPs may negatively regulate their ac-
tivity. Ligand-induced dimerization of EGFR/CD45 led
to functional inactivation [15]. Mutation of a single resi-
due in the wedge of CD45 abolished ligand-induced inac-
tivation [16], strongly supporting the model that
dimerization leads to wedge-mediated occlusion of the
catalytic sites. We have demonstrated that constitutively
dimeric RPTPα -P137C was inactive, since it failed to de-
phosphorylate and activate c-Src in vivo. Mutation of the
wedge rendered RPTPα -P137C active, while it did not af-
fect dimerization, demonstrating that inactivation of RP-
TPs by dimerization was dependent on the wedge [23].
RPTPα -F135C with a disulfide bridge at position 135
dimerized constitutively, like RPTPα -P137C, but was still
active, like wild type RPTPα . Apparently, dimerization-
induced inactivation requires a specific rotational cou-
pling, i.e. the monomers in the inhibited dimer need to
be oriented in a specific geometry with respect to each
other [23]. Ligand binding to the extracellular domain
may induce rotation of the monomers, relative to each
other, thus leading to activation or inactivation of RPT-
Pα , similar to ligand-induced rotation that has been sug-
gested to activate RPTKs [51,52].
Previously, we found that phorbol ester treatment of
cells led to activation of RPTPα , and to phosphorylation
of RPTPα  Ser180 and Ser204 [53,54]. These serine phos-
phorylation sites are localized close to the wedge, sug-
gesting that phosphorylation of these sites may interfere
with interactions of the wedge. Phosphorylation of
Ser180 and Ser204 may not affect dimerization per se,
but still may lead to opening up of the catalytic site and
thus to activation of RPTPα .
Since the crystal structures of RPTPµ -D1 and LAR did
not show dimers like RPTPα -D1 [9,11,12], the model that
RPTPs are regulated by dimerization has been the sub-
ject of debate. The transmembrane domain of RPTPα
was sufficient to drive dimerization. It will be interesting
to see whether the transmembrane domains of other RP-
TPs, including RPTPµ  and LAR, drive dimerization as
well. We propose that dimerization via the transmem-
brane domain of RPTPα  provides a conformational basis
for regulation by dimerization. Whether the dimer is in-
active depends on the exact topology of the intracellular
domain, which may be regulated by phosphorylation, by
interaction with other proteins, or by rotational coupling
for instance as a result of ligand binding to the extracel-
lular domain. Here we demonstrate that RPTPα  dimer-
ized in living cells for the first time, providing strong
support for the model that dimerization is involved in
regulation of RPTP activity.
Materials and Methods
Cells, plasmids and transfections
SK-N-MC neuroepithelioma cells were grown in Dulbec-
co's Modified Eagle's Medium, supplemented with 10%
Fetal Calf Serum. Expression vectors for chimeric RPT-
Pα  fusion proteins were generated by insertion of CFP
and YFP [30] (kind gift of Roger Y. Tsien) on PCR-ampli-
fied BglII-fragments into pSG-HA- RPTPα  [55] in which
BglII sites had been introduced at the appropriate sites,
position 792, 516, 250 or 200 (numbering according to
[56]) by site-directed mutagenesis. In RPTPα -200∆  ED,
the extracellular domain was deleted by deletion of an
EcoNI-PstI fragment encompassing residues 30-129.
RPTPα -EGFR-200 contains the extracellular domain of
RPTPα  (residues 1 - 142), fused to the transmembrane
domain and 34 residues of the cytoplasmic domain of the
EGFR (residues 646 - 702), comparable to RPTPα  200-
XFP. Expression vectors for EGFR-XFP were generated
by insertion of CFP and YFP into the endogenous BglII-
site in the human EGFR (at position Ile923). SK-N-MC
neuroepithelioma cells were grown on glass coverslips
and transiently transfected with equal amounts (5-10 µ g
total plasmid DNA per 5 cm dish) of CFP- and YFP-fu-
sion constructs by calcium phosphate precipitation ex-
actly as described [55] and assayed 48 h after
transfection.
Fluorescence Resonance Energy Transfer
For the FRET experiments, the cells were incubated at
220C in a HEPES buffered saline buffer (140 mM NaCl;
5 mM KCl; 2 mM CaCl2; 2 mM MgCl2; 10 mM HEPES;
10 mM glucose; 0.1% BSA; pH 7.50). We used a Leitz or-
thoplan upright microscope (Leitz GMBH, Wetzlar, Ger-
many) and a SPEX Fluorolog fluorimeter (SPEX
Industries, NJ) with two excitation monochromators
(slit width: 8 nm). Two filter sets (Ploemopak) were
used, the "CFP" filter set (filter #1) with an RKP510 dich-
roic mirror and a 490 nm long-pass emission filter, and
the "FRET" filter (filter #2), equipped with a dichroic
mirror RKP510 (reflection short-pass filter) and a
BP530-560 (band-pass) emission filter (Leitz GMBH,
Wetzlar, Germany). The fluorescence intensity was
quantified with a Photon Counting Tube (type 9862,
EMI Limited, Middlesex, England). The fluorescence in-BMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
tensities (obtained after excitation at 440 nm or 490 nm)
were corrected for differences in excitation light intensi-
ties, using the reference photomultiplier. Fluorescence
intensities were recorded from single living cells and cor-
rected for background, using adjacent non-transfected
cells. Routinely, we determined the F(440) and F(490)
ratio in 5 or more individual cells that expressed both the
CFP- and YFP-fusion proteins, using both filter sets. The
ratio of F(440) and F(490) was determined using the
FRET filter and consists of three terms: direct excitation
of YFP, residual CFP fluorescence, and FRET, as indicat-
ed in the following formula:
In this formula, γ  is a correction factor consisting of the
relative transmission efficiencies of the microscope and
the reflection efficiencies of the dichroic mirror at both
excitation wavelengths. In our microscope γ  was 1.0. The
molar extinction coefficients, ε CFP(440), ε YFP(440), and
ε YFP(490) are respectively, 32.5, 10.5 and 55.3 x 103 M-
1cm-1 [31]. QE(CFP/YFP) is the detection efficiency ratio
for CFP to YFP detection, and we estimated the ratio
QE(CFP/YFP) to be 0.2, based on the emission spectra of
CFP and YFP, and on the filter set used. R(CFP/YFP) is
the molar expression ratio in the cells of CFP and YFP-
tagged fusion proteins. E is the FRET efficiency in a CFP
and YFP labelled receptor dimer, which is dependent on
the distance and orientation of the fluorophores. α  is the
degree of dimerization, ranging from 0 (no dimerization)
to 1 (100% dimerization). The F(440)/F(490) ratio of
cells expressing YFP fusion proteins only, was
0.16± 0.04, consistent with the theoretical value (terms 2
and 3 of the formula are 0). In case there is no dimeriza-
tion and/or FRET does not occur, term 3 in the formula
above is 0 (α  and/or E is 0), and F(440)/F(490) is direct-
ly proportional to the R(CFP/YFP) (see Fig. 2B). F(440)/
F(490) ranges from 0.25 to 0.37 if R(CFP/YFP) ranges
from 0.5 to 1.5, and E *α  = 0 (no FRET and/or dimeriza-
tion) (Fig. 2B). If F(440)/F(490)>0.37 and R(CFP/YFP)
is close to 1.0, then term 3 in the formula above must be
>0, indicating that FRET occurs between CFP and YFP in
dimers of RPTPα  fusion proteins. Therefore, we set the
threshold level of F(440)/F(490) for FRET and dimeri-
zation at 0.37.
FLIM and SPIM
Both the SPIM and FLIM detector units were built on a
Leica DMR upright epifluorescence microscope. Both
detector systems are described in detail elsewhere
[28,38]. Briefly, FLIM was implemented in the frequen-
cy domain using a homodyne detection scheme and a
(wide field) RF-modulated image intensifier-CCD-cou-
pled detector unit, and the SPIM detector unit consisted
of an f/4 image spectrograph coupled to a back-illumi-
nated chilled CCD camera.
For SPIM, excitation was provided by a 100 W Hg Arc
lamp of which the 435 nm line was selected by inserting
an Omega (Brattleboro, VT, USA) 435DF10 bandpass fil-
ter in the excitation light path. The excitation light was
reflected onto the sample by an Omega 430DCLP dichro-
ic mirror. A Leica 63x PL Apo water objective (NA = 1.2)
was employed, using no coverslip, and immersing with
HEPES buffered saline buffer (see above) at 20° C. Resid-
ual excitation light was rejected using a Schott (Mainz,
Germany) GG455 longpass filter. In the spectrograph
(Chromex 250 is (Chromex Inc., Albuquerque, NM,
USA)) a 150 grooves/mm grating was used with a central
wavelength of 500 nm. Single cells were positioned by
aligning them across the entrance slit of the spec-
trograph (set at 200 µ m width corresponding with a line
of 3 µ m width in the object plane). Acquisition time was
1-2 s. Regions of the image spectrum corresponding to
the plasma membrane of labeled cells were distance av-
eraged (typically 5-10 rows of pixels) and the resulting
fluorescence spectra were corrected for background flu-
orescence and camera bias by background subtraction
using an extracellular region just next to the plasma
membrane region from the same spectral image.
For FLIM, the cells were excited with the 457 nm argon-
ion laser line modulated at 60.116 MHz and the CFP flu-
orescence was selectively imaged using an Omega 470
DCLP dichroic mirror and an Omega 487RDF42 band-
pass emission filter. 20 phase images (1-3 s each) were
taken (10 with increasing and 10 with decreasing the
phase allowing correction for photobleaching (which was
less than 10% in all cases)). Reference phase settings and
modulation were calibrated approximately every 30' by
measuring a glass microcuvette filled with an erythro-
sine-B solution in water (single component fluorescence
decay with a lifetime of 0.08 ns). The microscope setup,
lifetime-image calculation and image processing are de-
scribed in detail elsewhere [28].
Immunoblotting
Following transient transfection the cells were lysed in
cell lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl,
1.5 mM MgCl2, 1 mM EGTA, 1% Triton X-100, 10% glyc-
erol, 10 u/ml aprotinin, 1 µ M pMSF, 200 µ M sodium or-
thovanadate), and the amount of protein in the lysates
was determined. Subsequently, cell lysates containing
equal amounts of protein were loaded on SDS-PAGE gels
(7.5 - 12.5%, depending on the size of the construct). The
material on the gels was blotted onto PVDF membranes
by semi-dry blotting. The blots were blocked with 5%
non-fat milk in TBS-T (50 mM Tris pH 8.0, 150 mM Na-
Cl, 0.05% Tween-20) for 1 h, incubated with antibody inBMC Cell Biology (2001) 2:8 http://www.biomedcentral.com/1471-2121/2/8
milk for 1.5 h, washed extensively and incubated with the
appropriate horseradish peroxidase-conjugated second-
ary antibody for 1 h. Following extensive washing in TBS-
T, the blots were developed using enhanced chemilumi-
nescence. We used anti-GFP MAb (Transduction Labs,
Lexington, KY), anti-HA-tag MAb (12CA5), and affinity
purified anti-RPTPα  antibodies, raised against the com-
plete cytoplasmic domain (#5478) [57] as primary anti-
bodies.
Chemical cross-linking
Prior to cross-linking, transiently transfected SK-N-MC
neuroepithelioma cells were washed twice with ice cold
phosphate-buffered saline (PBS). Subsequently, the cells
were incubated with 2 mg/ml bis [sulfosuccinimi-
dyl]suberate, BS3 (Pierce, Rockford, IL) in PBS for 1 h on
ice. Following cross-linking, the cells were washed twice
with ice cold PBS, and the cross-linker was quenched
with 50 mM Tris for 15 min. The cells were lysed and al-
iquots of the lysates were run on a 5% SDS-PAGE gel,
blotted and probed, using anti-HA-tag antibodies as de-
scribed above.
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